Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Savolitinib is a novel reversible and competitive c-Met kinase inhibitor that has shown antitumor activity; IC50 values of this compound for c-Met and p-Met are 5 nM and 3 nM, respectively.…